drugset / Trial / NCT00857233
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of the study was to examine the safety and tolerability of memantine in outpatients with moderate to severe Alzheimer's Disease.
Timeline
- Start
- 2004-06
- Primary completion
- 2010-07
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 20 mg | Oral |